astrazeneca
-
Health & Medicine
AstraZeneca demonstrates oncology dominance with significant data readouts at ESMO Congress in Madrid
The European Society for Medical Oncology (ESMO) Congress, held this year in the vibrant clinical research hub of Madrid, has…
Read More » -
Health & Medicine
AstraZeneca faces a significant setback as its breast cancer pill camizestrant fails in a pivotal first-line treatment clinical trial
AstraZeneca announced on Friday that its experimental breast cancer medication, camizestrant, failed to meet its primary endpoint in the pivotal…
Read More »
